Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04620109
What this trial is testing

Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment

Who this might be right for
Corneal Neovascularization
Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd 62
Early research (Phase 1)Study completedNCT06074757
What this trial is testing

Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study

Who this might be right for
Metastatic Breast Cancer
Kashiv BioSciences, LLC 48
Early research (Phase 1)Study completedNCT00004057
What this trial is testing

Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT05508204
What this trial is testing

Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects

Who this might be right for
Healthy Volunteer
Chinook Therapeutics, Inc. 36
Early research (Phase 1)Study completedNCT02364635
What this trial is testing

Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects

Who this might be right for
Healthy
Pronova BioPharma 32
Early research (Phase 1)UnknownNCT04309968
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 186
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT03836833
What this trial is testing

Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation

Who this might be right for
HIV
Drugs for Neglected Diseases 50
Early research (Phase 1)Looking for participantsNCT07282145
What this trial is testing

Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers

Who this might be right for
Essential Hypertension
Bichedam Co., Ltd. 56
Large-scale testing (Phase 3)Study completedNCT06137092
What this trial is testing

RFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study

Who this might be right for
Severe Hemophilia A
AryoGen Pharmed Co. 50
Early research (Phase 1)Study completedNCT00817765
What this trial is testing

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

Who this might be right for
HIV InfectionFungal Infection
Radboud University Medical Center 24
Early research (Phase 1)Study completedNCT02744248
What this trial is testing

Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects

Who this might be right for
Magnetic Resonance Imaging
MegaPro Biomedical Co. Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00048906
What this trial is testing

Alpha-Galactosidase A Replacement Therapy for Fabry Disease

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 3
Post-approval studies (Phase 4)Study completedNCT04684381
What this trial is testing

Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell DiseasePharmacokinetics
Emmaus Medical, Inc. 13
Testing effectiveness (Phase 2)UnknownNCT02057887
What this trial is testing

Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)

Who this might be right for
Chronic Hepatitis C Virus Genotype I
Hanmi Pharmaceutical Company Limited 64
Early research (Phase 1)Study completedNCT05314933
What this trial is testing

Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers

Who this might be right for
Acute Nasopharyngitis
G.ST Antivirals GmbH 45
Testing effectiveness (Phase 2)Study completedNCT00265057
What this trial is testing

Study of ADH-1 Given Intravenously to Patients With Solid Tumors

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Study completedNCT06162728
What this trial is testing

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Spontaneous Urticaria
Jasper Therapeutics, Inc. 87
Early research (Phase 1)Study completedNCT01128634
What this trial is testing

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 32
Large-scale testing (Phase 3)Study completedNCT03935334
What this trial is testing

Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A or B With Inhibitor
AryoGen Pharmed Co. 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation